Drug Manufacturers - Specialty & Generic Industry | Healthcare Sector | Mr. Wook-Je Cho CEO | KRX SM Exchange | KR7000100008 ISIN |
KR Country | 1,999 Employees | - Last Dividend | 27 Dec 2023 Last Split | 21 Sep 2012 IPO Date |
Yuhan Corporation, established in 1926, stands as a distinguished entity in the pharmaceutical sector, both in South Korea and on a global scale. Its corporate headquarters are situated in Seoul, South Korea, a testament to its rich heritage and foundational roots within the country's pharmaceutical industry. The organization is deeply involved in a myriad of activities ranging from the research and development (R&D) to the manufacturing and international distribution of pharmaceutical products and intermediates. This extensive involvement has earmarked Yuhan Corporation as a multifaceted company that not only explores the depths of pharmaceutical innovations but also ensures the widespread availability of high-quality medical solutions across the world. Yuhan's commitment to healthcare excellence is reflected in their comprehensive array of product offerings, which cater to various medical needs and conditions, bolstering their reputation as a leading pharmaceutical company.
Yuhan Corporation offers a vast portfolio of products and services designed to meet the healthcare needs of patients worldwide. Below are key highlights from their offerings: